What is the expected normal total testosterone range for a 66‑year‑old man and how should low levels be evaluated and managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Testosterone Levels for a 66-Year-Old Man

For a 66-year-old man, total testosterone below 320 ng/dL (11 nmol/L) is considered low and warrants evaluation if accompanied by symptoms of testosterone deficiency, particularly sexual dysfunction.

Expected Normal Range

The normal total testosterone range for men in their 60s is approximately 196-859 ng/dL (6.8-29.8 nmol/L), with the lower 2.5th percentile threshold at 196 ng/dL for apparently healthy men 1. However, clinical guidelines use a more conservative cutoff:

  • Total testosterone <320 ng/dL (11 nmol/L) is the threshold used by major guidelines for diagnosing hypogonadism 2, 3
  • Free testosterone <64 pg/mL (220 pmol/L) is considered low 2
  • Approximately 30% of men over 70 have low testosterone levels 3

Diagnostic Evaluation

When to Measure Testosterone

Measure testosterone only when symptoms and signs of testosterone deficiency are present, including:

  • Sexual dysfunction (decreased libido, erectile dysfunction, reduced ejaculate volume)
  • Decreased energy and vitality
  • Loss of muscle mass and strength
  • Mood changes or depression
  • Loss of body/facial hair

How to Measure Properly

Obtain two separate morning (8-10 AM) fasting blood samples showing consistently low levels before diagnosing hypogonadism 2. This is critical because:

  • Testosterone exhibits diurnal variation (highest in morning)
  • Single measurements are unreliable due to episodic secretion
  • Even in older men, afternoon low values may normalize in morning 2

Measure Free Testosterone When:

Free testosterone measurement is recommended in conditions affecting sex hormone-binding globulin (SHBG) 2:

  • Decreased SHBG: Obesity, diabetes, hypothyroidism
  • Increased SHBG: Aging, cirrhosis, hyperthyroidism, HIV
  • Borderline total testosterone (200-400 ng/dL)

Rule Out Secondary Causes

Before diagnosing age-related low testosterone, exclude reversible causes 2:

  • Medications: Opioids, high-dose glucocorticoids
  • Medical conditions: Obesity, diabetes, sleep apnea, systemic illness
  • Pituitary/hypothalamic disorders: Check LH, FSH, prolactin to distinguish primary vs. secondary hypogonadism

Management Approach

Who Should Receive Testosterone Therapy

Initiate testosterone therapy only in men with both:

  1. Consistently low testosterone levels (<320 ng/dL)
  2. Sexual dysfunction who desire improvement in sexual function 3

Do NOT initiate testosterone therapy to improve energy, vitality, physical function, or cognition, as evidence does not support these indications 3.

Treatment Discussion

The 2020 ACP guideline emphasizes this is a conditional recommendation with low-certainty evidence 3. Discuss with patients:

  • Potential benefits (primarily sexual function improvement)
  • Harms (polycythemia, prostate monitoring requirements)
  • Costs
  • Patient preferences

Formulation Choice

Prefer intramuscular testosterone over transdermal formulations due to significantly lower cost with similar efficacy and safety 3.

Monitoring and Reassessment

  • Reevaluate symptoms at 12 months and periodically thereafter 3
  • Discontinue therapy if no improvement in sexual function 3
  • Monitor hematocrit, PSA, and metabolic parameters at 3 months, then every 6-12 months 4
  • Target testosterone levels in mid-normal range (450-600 ng/dL) 4

Critical Caveats

  1. No universal threshold exists below which all men develop symptoms 3. The relationship between testosterone levels and symptoms is complex and influenced by comorbidities.

  2. FDA approval limitation: Testosterone products are only FDA-approved for hypogonadism due to known pathological causes, not age-related decline alone 3.

  3. Treat underlying conditions first: Weight loss in obesity, discontinuing opioids, or managing sleep apnea may reverse hypogonadism and provide additional health benefits 2.

  4. Distinguish primary from secondary hypogonadism through LH/FSH measurement, as this has therapeutic implications for fertility and may uncover pituitary pathology requiring separate management 2.

  5. High interindividual variation: Even in the 8th-10th decades, testosterone decline is highly variable, with some men maintaining normal levels 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.